Cyclodextrin-Statin Wound Compositions for Chronic Wound Closure
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic wounds, such as diabetic foot ulcers and venous leg ulcers, are inadequate in promoting wound closure and inhibiting infection, as they fail to target the upregulation of Cav1, which inhibits keratinocyte migration and growth factor receptor antagonism, and do not address opportunistic pathogen colonization.
Innovation Solution
A synergistic combination of cyclodextrins and statins is used to downregulate Cav1, promote keratinocyte migration, enhance angiogenesis, and inhibit intracellular pathogen colonization through a multi-pronged approach, including the use of cyclodextrin-statin hydrogels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional treatments are used for chronic wounds, then basic wound care is provided, but wound closure is not promoted effectively and infection risk remains high
Solution Approach 1:
The treatment is segmented into multiple functional components: cyclodextrins for cholesterol depletion and Cav1 downregulation, statins for anti-inflammatory and antimicrobial effects, growth factors for tissue regeneration, and antibiotics for infection control. Each component targets specific aspects of wound healing independently, allowing comprehensive management of both closure and infection risks
Solution Approach 2:
The invention uses composite therapeutic formulations combining cyclodextrins, statins, growth factors, and antibiotics in single dressings or coordinated treatment regimens. This composite approach enables simultaneous delivery of multiple therapeutic agents that address both wound closure promotion and infection prevention, resolving the contradiction between these two outcomes
2Ease of operation
If Cav1 is upregulated in chronic wounds, then keratinocyte migration is inhibited, but this same upregulation contributes to persistent inflammation and non-healing
Solution Approach 1:
Cyclodextrins are used to extract and deplete cholesterol from wound tissue and keratinocyte membranes. This cholesterol depletion leads to downregulation of Cav1 expression, thereby removing the harmful effect of Cav1 upregulation that inhibits keratinocyte migration and sustains inflammation, without directly targeting Cav1 itself
Solution Approach 2:
The invention changes the biochemical parameters of the wound environment by depleting cholesterol and reducing Cav1 expression levels. This parameter change transforms the wound state from persistent inflammation with inhibited migration to a state conducive to keratinocyte migration and healing progression
3Productivity
If growth factor-based therapies are used, then tissue regeneration is promoted, but Cav1 upregulation antagonizes growth factor receptors reducing efficacy
Solution Approach 1:
Cyclodextrins and statins are applied preliminarily to deplete cholesterol and downregulate Cav1 expression before or concurrent with growth factor administration. This preliminary action removes the antagonistic effect of Cav1 on growth factor receptors, ensuring that subsequent growth factor therapy can effectively promote tissue regeneration without being blocked by Cav1 upregulation
4Duration of action of stationary object
If chronic wounds are left untreated, then natural healing process continues, but prolonged inflammation hinders epithelial closure and delays healing
Solution Approach 1:
The invention converts the harmful persistent inflammation into a beneficial healing response by using statins to modulate inflammatory pathways and cyclodextrins to reduce Cav1-mediated inflammation. This transformation changes the ineffective chronic inflammation into an effective acute-like inflammatory response that promotes healing progression
Solution Approach 2:
Cyclodextrins and statins act as intermediary agents that mediate between the persistent inflammatory state and the desired healing response. They intermediate by depleting cholesterol, downregulating Cav1, and modulating inflammatory pathways, thereby bridging the gap between chronic inflammation and effective wound healing
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination effectively enhances wound closure, promotes angiogenesis, and reduces pathogen colonization, converting chronic wounds into acute healing wounds by addressing multiple cellular processes.
Implementation Method 1
They are able to form inclusion complexes with a wide variety of hydrophobic molecules by virtue of having a relatively hydrophilic outer surface that can dissolve in water and a relatively hydrophobic cavity which provide a hydrophobic matrix to capture appropriately sized non-polar moieties
Implementation Method 2
due to their ability to bind cholesterol and free fatty acids, cyclodextrins (methyl-β-cyclodextrin (MβCD) and hydroxypropyl-β-cyclodextrin (HβCD), in particular) have been widely used in extracting cholesterol from plasma membranes
Data Source
AI summary
Disclosed herein are therapeutics compositions including one or more active agents, for instance a statin, cyclodextrin, or combination thereof. The compositions are useful in the treatment of tissue injuries, including wounds, as well as skin inflammation and infections.